MONTEROSA - Italian Multicenter Observational Study to Evaluate Time to Clinical Hepatic Decompensation, Quality of Life, Effectiveness, and Safety of Tremelimumab Plus Durvalumab in Patients With Advanced or Unresectable Hepatocellular Carcinoma Who Have Received no Prior Systemic Treatment.
Abroad (travel likely)Recruiting
Conditions
Hepatocellular Carcinoma
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Research site, Ancona, Italy
Research site, Bergamo, Italy
Research site, Foggia, Italy
Research site, Meldola, Italy
Research site, Milan, Italy
Research site, Milan, Italy
Research site, Modena, Italy
Research site, Naples, Italy
Research site, Padova, Italy
Research site, Palermo, Italy
Research site, Pisa, Italy
Research site, Pozzuoli, Italy
Research site, Roma, Italy
Research site, Rozzano, Italy
Research site, Torino, Italy
Research site, Verona, Italy